Global Bioprinting 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI11241113

Publication Date:

November 18, 2024

Pages:

109

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Bioprinting is an advanced form of 3D printing that involves the creation of biological structures using cells, growth factors, and biomaterials, often referred to as bio-inks. This technology has the potential to revolutionize medicine by enabling the fabrication of complex tissue structures, and potentially even entire organs, for use in medical research, drug testing, and regenerative medicine.
The global Bioprinting market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淏ioprinting Industry Forecast鈥� looks at past sales and reviews total world Bioprinting sales in 2022, providing a comprehensive analysis by region and market sector of projected Bioprinting sales for 2023 through 2029. With Bioprinting sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bioprinting industry.
This Insight Report provides a comprehensive analysis of the global Bioprinting landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Bioprinting portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Bioprinting market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bioprinting and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bioprinting.
The market for 3D bioink and bioprinting is experiencing rapid growth due to its potential to revolutionize healthcare and regenerative medicine. This technology has applications in drug testing, disease modeling, and ultimately, the generation of functional human organs for transplantation. The market is driven by increased investments in research and development, collaborations between biotechnology companies and academic institutions, and a growing demand for personalized medicine. North America, Europe, and Asia-Pacific are the leading regions in terms of market adoption, with major players in the bioprinting industry continuously innovating and expanding their product portfolios.
This report presents a comprehensive overview, market shares, and growth opportunities of Bioprinting market by product type, application, key players and key regions and countries.
Segmentation by Type:
Bio-inks
Bioprinters
3D Models
Segmentation by Application:
Research Application
Clinical Application
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Bio-inks
Bioprinters
3D Models
Segmentation by Application:
Research Application
Clinical Application
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
EnvisionTEC GmbH
Aspect Biosystems Ltd.
Regenovo Biotechnology Co., Ltd.
regenHU
GeSiM
CELLINK
Cyfuse Biomedical K.K.
ROKIT Healthcare
TeVido BioDevices
Advanced Solutions Life Sciences
Organovo Holdings Inc.
Allevi Inc.
Poietis
Nano3D Biosciences, Inc.
Digilab Inc

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Bioprinting 麻豆原创 Size 2019-2030
2.1.2 Bioprinting 麻豆原创 Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Bioprinting by Country/Region, 2019, 2023 & 2030
2.2 Bioprinting Segment by Type
2.2.1 Bio-inks
2.2.2 Bioprinters
2.2.3 3D Models
2.3 Bioprinting 麻豆原创 Size by Type
2.3.1 Bioprinting 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Bioprinting 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Bioprinting Segment by Application
2.4.1 Research Application
2.4.2 Clinical Application
2.4.3 Other
2.5 Bioprinting 麻豆原创 Size by Application
2.5.1 Bioprinting 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Bioprinting 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Bioprinting 麻豆原创 Size by Player
3.1 Bioprinting 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Bioprinting Revenue by Player (2019-2024)
3.1.2 Global Bioprinting Revenue 麻豆原创 Share by Player (2019-2024)
3.2 Global Bioprinting Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Bioprinting by Region
4.1 Bioprinting 麻豆原创 Size by Region (2019-2024)
4.2 Global Bioprinting Annual Revenue by Country/Region (2019-2024)
4.3 Americas Bioprinting 麻豆原创 Size Growth (2019-2024)
4.4 APAC Bioprinting 麻豆原创 Size Growth (2019-2024)
4.5 Europe Bioprinting 麻豆原创 Size Growth (2019-2024)
4.6 Middle East & Africa Bioprinting 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Bioprinting 麻豆原创 Size by Country (2019-2024)
5.2 Americas Bioprinting 麻豆原创 Size by Type (2019-2024)
5.3 Americas Bioprinting 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bioprinting 麻豆原创 Size by Region (2019-2024)
6.2 APAC Bioprinting 麻豆原创 Size by Type (2019-2024)
6.3 APAC Bioprinting 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Bioprinting 麻豆原创 Size by Country (2019-2024)
7.2 Europe Bioprinting 麻豆原创 Size by Type (2019-2024)
7.3 Europe Bioprinting 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bioprinting by Region (2019-2024)
8.2 Middle East & Africa Bioprinting 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Bioprinting 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Bioprinting 麻豆原创 Forecast
10.1 Global Bioprinting Forecast by Region (2025-2030)
10.1.1 Global Bioprinting Forecast by Region (2025-2030)
10.1.2 Americas Bioprinting Forecast
10.1.3 APAC Bioprinting Forecast
10.1.4 Europe Bioprinting Forecast
10.1.5 Middle East & Africa Bioprinting Forecast
10.2 Americas Bioprinting Forecast by Country (2025-2030)
10.2.1 United States 麻豆原创 Bioprinting Forecast
10.2.2 Canada 麻豆原创 Bioprinting Forecast
10.2.3 Mexico 麻豆原创 Bioprinting Forecast
10.2.4 Brazil 麻豆原创 Bioprinting Forecast
10.3 APAC Bioprinting Forecast by Region (2025-2030)
10.3.1 China Bioprinting 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Bioprinting Forecast
10.3.3 Korea 麻豆原创 Bioprinting Forecast
10.3.4 Southeast Asia 麻豆原创 Bioprinting Forecast
10.3.5 India 麻豆原创 Bioprinting Forecast
10.3.6 Australia 麻豆原创 Bioprinting Forecast
10.4 Europe Bioprinting Forecast by Country (2025-2030)
10.4.1 Germany 麻豆原创 Bioprinting Forecast
10.4.2 France 麻豆原创 Bioprinting Forecast
10.4.3 UK 麻豆原创 Bioprinting Forecast
10.4.4 Italy 麻豆原创 Bioprinting Forecast
10.4.5 Russia 麻豆原创 Bioprinting Forecast
10.5 Middle East & Africa Bioprinting Forecast by Region (2025-2030)
10.5.1 Egypt 麻豆原创 Bioprinting Forecast
10.5.2 South Africa 麻豆原创 Bioprinting Forecast
10.5.3 Israel 麻豆原创 Bioprinting Forecast
10.5.4 Turkey 麻豆原创 Bioprinting Forecast
10.6 Global Bioprinting Forecast by Type (2025-2030)
10.7 Global Bioprinting Forecast by Application (2025-2030)
10.7.1 GCC Countries 麻豆原创 Bioprinting Forecast
11 Key Players Analysis
11.1 EnvisionTEC GmbH
11.1.1 EnvisionTEC GmbH Company Information
11.1.2 EnvisionTEC GmbH Bioprinting Product Offered
11.1.3 EnvisionTEC GmbH Bioprinting Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 EnvisionTEC GmbH Main Business Overview
11.1.5 EnvisionTEC GmbH Latest Developments
11.2 Aspect Biosystems Ltd.
11.2.1 Aspect Biosystems Ltd. Company Information
11.2.2 Aspect Biosystems Ltd. Bioprinting Product Offered
11.2.3 Aspect Biosystems Ltd. Bioprinting Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Aspect Biosystems Ltd. Main Business Overview
11.2.5 Aspect Biosystems Ltd. Latest Developments
11.3 Regenovo Biotechnology Co., Ltd.
11.3.1 Regenovo Biotechnology Co., Ltd. Company Information
11.3.2 Regenovo Biotechnology Co., Ltd. Bioprinting Product Offered
11.3.3 Regenovo Biotechnology Co., Ltd. Bioprinting Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Regenovo Biotechnology Co., Ltd. Main Business Overview
11.3.5 Regenovo Biotechnology Co., Ltd. Latest Developments
11.4 regenHU
11.4.1 regenHU Company Information
11.4.2 regenHU Bioprinting Product Offered
11.4.3 regenHU Bioprinting Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 regenHU Main Business Overview
11.4.5 regenHU Latest Developments
11.5 GeSiM
11.5.1 GeSiM Company Information
11.5.2 GeSiM Bioprinting Product Offered
11.5.3 GeSiM Bioprinting Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 GeSiM Main Business Overview
11.5.5 GeSiM Latest Developments
11.6 CELLINK
11.6.1 CELLINK Company Information
11.6.2 CELLINK Bioprinting Product Offered
11.6.3 CELLINK Bioprinting Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 CELLINK Main Business Overview
11.6.5 CELLINK Latest Developments
11.7 Cyfuse Biomedical K.K.
11.7.1 Cyfuse Biomedical K.K. Company Information
11.7.2 Cyfuse Biomedical K.K. Bioprinting Product Offered
11.7.3 Cyfuse Biomedical K.K. Bioprinting Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Cyfuse Biomedical K.K. Main Business Overview
11.7.5 Cyfuse Biomedical K.K. Latest Developments
11.8 ROKIT Healthcare
11.8.1 ROKIT Healthcare Company Information
11.8.2 ROKIT Healthcare Bioprinting Product Offered
11.8.3 ROKIT Healthcare Bioprinting Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 ROKIT Healthcare Main Business Overview
11.8.5 ROKIT Healthcare Latest Developments
11.9 TeVido BioDevices
11.9.1 TeVido BioDevices Company Information
11.9.2 TeVido BioDevices Bioprinting Product Offered
11.9.3 TeVido BioDevices Bioprinting Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 TeVido BioDevices Main Business Overview
11.9.5 TeVido BioDevices Latest Developments
11.10 Advanced Solutions Life Sciences
11.10.1 Advanced Solutions Life Sciences Company Information
11.10.2 Advanced Solutions Life Sciences Bioprinting Product Offered
11.10.3 Advanced Solutions Life Sciences Bioprinting Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Advanced Solutions Life Sciences Main Business Overview
11.10.5 Advanced Solutions Life Sciences Latest Developments
11.11 Organovo Holdings Inc.
11.11.1 Organovo Holdings Inc. Company Information
11.11.2 Organovo Holdings Inc. Bioprinting Product Offered
11.11.3 Organovo Holdings Inc. Bioprinting Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 Organovo Holdings Inc. Main Business Overview
11.11.5 Organovo Holdings Inc. Latest Developments
11.12 Allevi Inc.
11.12.1 Allevi Inc. Company Information
11.12.2 Allevi Inc. Bioprinting Product Offered
11.12.3 Allevi Inc. Bioprinting Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 Allevi Inc. Main Business Overview
11.12.5 Allevi Inc. Latest Developments
11.13 Poietis
11.13.1 Poietis Company Information
11.13.2 Poietis Bioprinting Product Offered
11.13.3 Poietis Bioprinting Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 Poietis Main Business Overview
11.13.5 Poietis Latest Developments
11.14 Nano3D Biosciences, Inc.
11.14.1 Nano3D Biosciences, Inc. Company Information
11.14.2 Nano3D Biosciences, Inc. Bioprinting Product Offered
11.14.3 Nano3D Biosciences, Inc. Bioprinting Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.14.4 Nano3D Biosciences, Inc. Main Business Overview
11.14.5 Nano3D Biosciences, Inc. Latest Developments
11.15 Digilab Inc
11.15.1 Digilab Inc Company Information
11.15.2 Digilab Inc Bioprinting Product Offered
11.15.3 Digilab Inc Bioprinting Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.15.4 Digilab Inc Main Business Overview
11.15.5 Digilab Inc Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.